Metabolic characteristics of patients with MetALD : Caveats of a new definition
Liver International · 2024
DOI: 10.1111/liv.16034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Erin Petrie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Nutrition and Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Nutrition Surveys. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Recently, a new entity was introduced, MetALD, which includes patients with metabolic dysfunction‐associated steatotic liver disease (MASLD), who consume moderate amounts of alcohol. However, little is known regarding the metabolic and clinical characteristics of these patients.
Methods
Data from the National Health and Nutrition Examination Surveys 2017–2020 was used. Participants without valid transient elastography (TE) measurements, incomplete alcohol consumption report, or with alternative etiologies of liver steatosis were excluded.
Results
A total of 6901 patients were included in the study, of which 106 (1.5%) had MetALD. Overall, MetALD patients showed a metabolic profile that was more similar to patients with alcohol related liver disease (ALD) than MASLD. Specifically, while patients with MetALD showed values in‐between MASLD and ALD for body mass index (BMI), aspartate transaminase (AST), alanine transaminase (ALT), gamma glutamyltransferase (GGT) and haemoglobin A1c, they had similar high‐density lipoprotein cholesterol (HDL‐C), blood pressure, prevalence of diabetes and insulin resistance to ALD patients. Increasing alcohol consumption was associated with lower insulin resistance and A1c and higher triglycerides, HDL‐C and blood pressure. Moreover, while AST, ALT and GGT increased with alcohol consumption, this did not translate into worse hepatic steatosis or liver fibrosis by TE.
Conclusions
MetALD patients share some characteristics with MASLD, but they resemble ALD patients more, especially after adjusting for BMI. Alcohol consumption produces a dissociation between insulin resistance and some cardiometabolic risk factors (blood pressure and HDL‐C), which may make the current classification of patients challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Nutrition and Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- UAB Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Fernando Bril
Zitieren
APA
Petrie, E., Gray, M., & Bril, F. (2024). Metabolic characteristics of patients with MetALD : Caveats of a new definition. Liver International. https://doi.org/10.1111/liv.16034
Vancouver
Petrie E, Gray M, Bril F. Metabolic characteristics of patients with MetALD : Caveats of a new definition. Liver International. 2024. doi:10.1111/liv.16034
BibTeX
@article{Petrie2024,
author = {Petrie, Erin and Gray, Meagan and Bril, Fernando},
title = {Metabolic characteristics of patients with MetALD : Caveats of a new definition},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16034}
}
EUVIMED